# Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients

> **NCT05279586** · EARLY_PHASE1 · UNKNOWN · sponsor: **Madonna Magdy Fahmy** · enrollment: 316 (estimated)

## Conditions studied

- Hepatic Encephalopathy

## Interventions

- **DRUG:** lactulose
- **DRUG:** colistin

## Key facts

- **NCT ID:** NCT05279586
- **Lead sponsor:** Madonna Magdy Fahmy
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03
- **Primary completion:** 2023-02
- **Final completion:** 2023-03
- **Target enrollment:** 316 (ESTIMATED)
- **Last updated:** 2022-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05279586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05279586, "Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhotic Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05279586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*